Posts in category: Uncategorized

Using data from over 900 participants in a large, diverse, and national sample of Canadian adolescents and young adults from the Canadian Study of Adolescent Health Behaviors, a new study published in the journal Sexual Health has found significant associations between sex work and muscle dysmorphia.

Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a promising new treatment option for people with pancreatic cancer. Researchers from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) suggest that when used in a form that can be delivered directly into the tumor cell, polyinosine–polycytidylic acid (pIC) suppresses tumor growth, induces cancer cell death and enhances survival in animal models with the most common form of pancreatic cancer.

New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, has found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly more flares and lower Boolean 2.0 remission rates compared with those who continued treatment.

New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years following autologous stem cell transplant.

Nursing home residents have an increasing diversity in the level of care required—ranging from short term post-acute care stays that are focused on rehabilitation, to more intensive nursing care.

New research from Cleveland Clinic has identified a link between sleep apnea and the development of atrial fibrillation, a common heart rhythm disorder.

By MICHAEL MIYOBA

FORMER Nkana and national team coach Beston Chambeshi has promised to help Konkola Blades avoid relegation after taking over as head coach at the Chililabombwe-based MTN Zambia Super League outfit.

Speaking after he was unveiled as the new head gaffer, the veteran coach who last led Konkola Blades as head coach in 2013 said he does not fear any challenges as he takes over a side that is languishing on 15th position on the Super League table with 10 points collected from 11 games.

Chambeshi said he was happy that Blades have expressed confidence in him to take over as head coach. The appointment came a few hours after Blades lost to his former club Nkana FC in a midweek fixture played on Wednesday.

 “I am happy to be here. I am a coach who doesn’t fear any challenges and like I said, we will work hard to ensure that we finish in a strong position,” Chambeshi said.

Chambeshi noted the need for the team to work in harmony to achieve the set objective of finishing in a strong position.

“We all know that the team has suffered a bit of some setbacks in the previous games but working as a unit, we will definitely achieve our desired results. We will definitely get into the right position in the league,” Chambeshi said.

Club chairman Davy Mubita said Chambeshi’s main objective as he returns to Chililabombwe is to turn the fortunes of the club around up to the end of the season.

As one of the experienced coaches in the country, Chambeshi previously drilled Power Dynamos, Kansanshi Dynamos, Chambishi, Lumwana Radiants and Nkana FC before returning to Blades.

Chambeshi replaced Enos Silwimba who has been relegated to the position of first assistant coach while Lewington Mujembe and John Mukonje will be second assistants.

Blades confirmed in a statement that the other coaches will be reassigned with other duties.

Scientists at La Jolla Institute for Immunology (LJI) are investigating a talented type of T cell.

Worldwide, cardiac arrest among hospitalized people of all ages is a high-risk event associated with significant disease and death. To address a growing need to improve the quality standards for responding to an in-hospital cardiac arrest (IHCA), the International Liaison Committee on Resuscitation (ILCOR) has identified 10 steps that can lead to better patient outcomes and survival.

Researchers from Trinity, in collaboration with Artelo Biosciences, have made a breakthrough in cancer cachexia. Their work shows that the drug ART27.13 protects against the muscle degeneration associated with colon and lung cancers (cachexia) and believe it may also positively impact life expectancy.